Physician

Srikanth Mukkera, M.D.

According to 2025 Medicare claims, Srikanth Mukkera, M.D. (NPI: 1891006482) practices rheumatology in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is PERMIAN ARTHRITIS AND RHEUMATOLOGY CENTER (NPI: 1225883564; TIN: 991684042) and primary practice location at 79765-8615. Mukkera is affiliated with the Texoma Clinical Partners ACO, LLC (ACO ID: A4585) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mukkera's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 165 traditional Medicare patients, billed 610 HCPCS/CPT codes, and received $34,556 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,580 prescription claims across 317 beneficiaries totaling $4,739,192 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 40 records totaling $831. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $24,265 and ending at $34,556. Concurrently, Part D prescription costs have risen steadily, from $211,883 to $4,739,192. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	106	1,084	$24,265
2016	499	6,508	$109,444
2017	861	11,692	$203,467
2018	1,008	14,231	$252,227
2019	826	9,176	$145,274
2020	96	576	$21,476
2021	213	1,632	$47,010
2022	190	692	$35,413
2023	172	714	$33,501
2024	165	610	$34,556

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	109	487	$211,883
2016	239	1,932	$305,553
2017	506	4,817	$1,365,456
2018	651	7,011	$2,688,786
2019	560	5,400	$2,049,358
2020	160	606	$563,357
2021	268	1,525	$1,531,428
2022	303	2,761	$4,623,958
2023	288	2,595	$4,639,232
2024	317	2,580	$4,739,192

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	44	44	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	140	267	$89
20610	Aspiration and/or injection of fluid from large joint	22	32	$58
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	17	17	$53
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	29	222	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	134	4,140	$886,964
Enbrel Sureclick	Etanercept	102	2,958	$761,026
Xeljanz Xr	Tofacitinib Citrate	80	2,400	$464,236
Cortrophin	Corticotropin	11	187	$379,130
Humira(Cf) Pen	Adalimumab	42	1,260	$298,501

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	40	$831	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Srikanth Mukkera, M.D.?

Tedicare shows public-source Medicare data for Srikanth Mukkera, M.D. (NPI 1891006482), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Srikanth Mukkera, M.D. have ACO affiliation data?

Srikanth Mukkera, M.D. is shown with ACO affiliation data for Texoma Clinical Partners ACO, LLC (MSSP, ACO ID A4585) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Srikanth Mukkera, M.D.?

Srikanth Mukkera, M.D. is linked to PERMIAN ARTHRITIS AND RHEUMATOLOGY CENTER (billing NPI 1225883564) in the available physician profile data.

Does Srikanth Mukkera, M.D. have Open Payments data?

Srikanth Mukkera, M.D. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.